Ctdna-Guided Therapy In Stage Ii Colon Cancer | Nejm

DYNAMIC: ctDNA guiding adjuvant chemotherapy in stage II colon cancer

Illumina Oncology | ctDNA-guided treatment in colorectal cancer

Highlights on adjuvant chemotherapy of stage II colon cancer: The DYNAMIC Trial

European Society for Medical Oncology (ESMO)

Can we refine the selection for adjuvant treatment in stage II colon cancer?

NRG-GI005: ctDNA predicts adjuvant chemo in stage II colon cancer

Circulating tumour DNA analysis can help identify the need for CT in stage II colon cancer

2021 West Oncology | Gastrointestinal Cancers | ctDNA Analysis in Colorectal Cancer

Total Health | Oncology

A Positive ctDNA Test after Adjuvant Therapy: 2023 Best of GI

Total Health | Oncology

COBRA: ctDNA to help decide which patients with colon cancer will benefit from adjuvant chemotherapy

The utility of ctDNA in colorectal cancer management

Debate: Is circulating tumor DNA ready to guide adjuvant therapy in colon cancer? - Yes

Use of ctDNA in Low Risk Stage II colon cancer

OncBrothers: Practice-Changing Cancer Discussions

Stage II Colon Cancer: Can We Refine the Selection for Adjuvant Treatment?

ctDNA and MRD | 2023 Best of GI Cancer Conference

Total Health | Oncology

Ongoing clinical trials on using ctDNA results to guide GI cancer management

Efficacy of Adjuvant Therapy in Stage II Colon Cancer

Circulating tumour DNA analysis can help identify the need for adjuvant CT in stage II colon cancer

What's new for colorectal cancer treatment?

The emerging role of ctDNA in cancer diagnostics

How can we use ctDNA to improve adjuvant treatment for colon cancer?